Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 studyMax S. Topp, Hagop M. Kantarjian, Josep‐María Ribera et al.|The Lancet Oncology|2014Cited by 1.3k
The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AMLSabine Käyser, Konstanze Döhner, Jürgen Krauter et al.|Blood|2010Cited by 485
<i>RUNX1</i>Mutations in Acute Myeloid Leukemia: Results From a Comprehensive Genetic and Clinical Analysis From the AML Study GroupVerena I. Gaidzik, Konstanze Döhner, Lars Bullinger et al.|Journal of Clinical Oncology|2011Cited by 450
Differential impact of allelic ratio and insertion site in FLT3-ITD–positive AML with respect to allogeneic transplantationRichard F. Schlenk, Konstanze Döhner, Sabine Käyser et al.|Blood|2014Cited by 400
Monosomal karyotype in adult acute myeloid leukemia: prognostic impact and outcome after different treatment strategiesSabine Käyser, Manuela Zucknick, Konstanze Döhner et al.|Blood|2011Cited by 151